Determining targets for antiretroviral drug concentrations: a causal framework illustrated with pediatric efavirenz data from the CHAPAS-3 trial
<p><strong>Background: </strong>Determining a therapeutic window for maintaining antiretroviral drug concentrations within an appropriate range is required for identifying effective dosing regimens. The limits of this window are typically calculated using predictive models...
Main Authors: | Schomaker, M, Denti, P, Bienczak, A, Burger, D, Díaz, I, Gibb, DM, Walker, AS, McIlleron, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2024
|
Similar Items
-
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
by: Bienczak, A, et al.
Published: (2016) -
Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
by: Bienczak, A, et al.
Published: (2016) -
Evaluation of an immunoassay for determination of plasma efavirenz concentrations in resource‐limited settings
by: Alemseged Abdissa, et al.
Published: (2014-01-01) -
Pharmacokinetics of antiretroviral drugs in infancy
by: Helen McIlleron, et al.
Published: (2009-12-01) -
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets
by: Bienczak, A, et al.
Published: (2017)